Cleared Special

4F Infiniti Angiographic Catheter, 4F & 5F Nylex Angiography Catheters, 4F & 5F Tempo Angiography Catheters (K181836) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
29d
Days
Class 2
Risk

K181836 is an FDA 510(k) clearance for the 4F Infiniti Angiographic Catheter, 4F & 5F Nylex Angiography Catheters, 4F & .... Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Cordis, A Cardinal Health Company (Milpitas, US). The FDA issued a Cleared decision on August 8, 2018 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Cordis, A Cardinal Health Company devices

Submission Details

510(k) Number K181836 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 2018
Decision Date August 08, 2018
Days to Decision 29 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 125d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 194
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K181836.
Arterial Pressure Monitoring Set/Tray
K180792 · Cook Incorporated · Nov 2018
Polyethylene Catheter
K180286 · Cook Incorporated · Oct 2018
Royal Flush Plus High-Flow Catheter
K180054 · Cook Incorporated · Oct 2018
AngioDynamics, Inc. Soft-Vu and Mariner Angiographic Catheters
K173762 · AngioDynamics, Inc. · Jul 2018
High-Flo Silver Polyethylene Catheter
K172635 · Cook Incorporated · Apr 2018
Surefire Spark Infusion System
K180677 · Surefire Medical, Inc. · Apr 2018